Track topics on Twitter Track topics that are important to you
DNAnexus has secured $58m financing, including a strategic investment from Microsoft, in order to further develop its translational medicine solutions.
Mountain View, California-based DNAnexus has closed a $58 million financing round led by Foresite Capital. Microsoft, TPG Biotech, WuXi NextCODE, GV (formerly Google Ventures), MidCap Financial and Cl...
The cash will support expansion in translational informatics, clinical trials, and broadened use of biomedical data.
Investment led by Foresite Capital with strategic investment by Microsoft will support expansion in translational informatics, clinical trials, and broadened use of biomedical dat...
Global research consortium leverages DNAnexus cloud-based platform to scale analyses for the world’s animal kingdom DNAnexus, the global leader in genome informatics and dat...
St. Jude Cloud lets researchers view over 5,000 whole-genome, 5,000 whole-exome and 1,200 RNA-Seq datasets from more than 5,000 pediatric cancer patients and survivors.
DNAnexus is powering the genomics revolution with an enterprise-level solution that combines cloud computing with advanced bioinformatics. The DNAnexus team is made up of experts ...
DNAnexus combines a cloud computing infrastructure with scalable systems design and advanced bioinformatics to address the data storage, management and analysis challenges inheren...
We have published hundreds of DNAnexus Inc. news stories on BioPortfolio along with dozens of DNAnexus Inc. Clinical Trials and PubMed Articles about DNAnexus Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DNAnexus Inc. Companies in our database. You can also find out about relevant DNAnexus Inc. Drugs and Medications on this site too.